Highlights from The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) meeting, held on 20 to 23 February 2023.
The EMA Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorisation for Akeega (niraparib/abiraterone acetate) for the treatment of metastatic castration-resistant prostate cancer with...